Sweet's syndrome associated with myelodysplastic syndrome presenting as periorbital cellulitis.
Khatri
Mishri Lal
ML
Department of Dermatology, Saudi Hospital at Hajjah, Sana'a, Yemen. mishrik1@yahoo.co.in
Taha
Mahmood
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D003907:Dexamethasone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000175:diagnosis; D009916:Orbital Diseases / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D011239:Prednisolone / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D012909:Snake Bites / Q000150:complications; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D016463:Sweet Syndrome / Q000150:complications* / Q000175:diagnosis; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D011239:Prednisolone